Intraarticular infliximab therapy in patients with juvenile idiopathic arthritis: the role of musculoskeletal ultrasound and disease activity scores in monitoring therapy response.

CONCLUSIONS: This study showed promising results, good safety and potential for the clinical benefit of intraarticular infliximab treatment in a selected group of patients with oligoarticular subtype of JIA. PMID: 29600948 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29600948?dopt=Abstract

Source: Clinical and Experimental Rheumatology - April 1, 2018 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research